Sanjay Chanda

Sanjay Chanda

Corporate Officer/Principal en AN2 THERAPEUTICS, INC. .

Fortuna: 166 428 $ al 30/06/2026

61 años
Health Technology
Consumer Services

Perfil

Dr. Sanjay Chanda is a Chief Development Officer at AN2 Therapeutics, Inc. and a Chief Development Officer at Cortene, Inc. Dr. Chanda was previously employed as a Co-Founder by Auration Biotech, Inc., a Senior Vice President-Drug Development by Anacor Pharmaceuticals LLC, and a Chief Development Officer by Tioma Therapeutics, Inc. He received his undergraduate degree from Birla Institute of Technology & Science, a graduate degree from Birla Institute of Technology & Science and a doctorate degree from Northeast Louisiana University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/03/2026 34.386 ( 0,1 % ) 166 428 $ 30/06/2026

Cargos activos de Sanjay Chanda

EmpresasCargoInicio
AN2 THERAPEUTICS, INC. Corporate Officer/Principal 01/11/2019
Corporate Officer/Principal 01/02/2017

Antiguos cargos conocidos de Sanjay Chanda.

EmpresasCargoFin
Corporate Officer/Principal 01/08/2017
ANACOR PHARMACEUTICALS INC Corporate Officer/Principal 01/10/2016
Fundador -
Ver el detalle de la experiencia de Sanjay Chanda.

Formación de Sanjay Chanda.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

26

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology